Somaxon has gotten a big boost after Proctor & Gamble promised to help them sell Silenor to thousands of U.S. doctors and pharmacies. Both companies have agreed in principle to start the marketing efforts for the new sleep drug this September.
The deal also places Procter & Gamble first in line to negotiate for the rights to develop and market an over-the-counter version of Silenor in the United States. However, Somaxon would have to win FDA approval first before the drug could be sold without a prescription.
Also see other interesting tags at SleepZine: doctors, fda, fda approval, launch, marketing efforts, pharmacies, principle, procter gamble, proctor gamble, sleep, united states
More similar categories at Sleepzine: Sleeping Pills.
